Management Change/Compensation Form 8 K

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 8, 2024, GlobeStar Therapeutics Corporation, a Wyoming corporation (the "Company") received notice of the resignation of Robert Chicoski as Chief Financial Officer of the Company. In connection with his resignation, Mr. Chicoski relinquished his role as the Company's "Principal Financial and Accounting Officer" for Securities and Exchange Commission reporting purposes. Mr. Chicoski's decision to resign was not the result of any disagreement with the Company.